1-PYRIDIN-4-YL-UREA DERIVATIVES

Details for Australian Patent Application No. 2003270186 (hide)

Owner ACTELION PHARMACEUTICALS LTD

Inventors Mathys, Boris; Binkert, Christoph; Mueller, Claus; Aissaoui, Hamed; Weller, Thomas; Clozel, Martine; Scherz, Michael; Nayler, Oliver; Velker, Jorg

Agent A J Park

Pub. Number AU-A-2003270186

PCT Number PCT/EP03/10154

PCT Pub. Number WO2004/026836

Priority PCT/EP02/10417 17.09.02 EP

Filing date 12 September 2003

Wipo publication date 8 April 2004

International Classifications

C07D 215/00 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

15 January 2004 Complete Application Filed

  Priority application(s): PCT/EP02/10417 17.09.02 EP

20 May 2004 Application Open to Public Inspection

  Published as AU-A-2003270186

27 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003270187-A NOVEL MECHANISM FOR HIV-1 ENTRY INTO HOST CELLS AND PEPTIDES INHIBITING THIS MECHANISM

2003270185-METHOD FOR TREATING CELL CULTURES